Literature DB >> 26975877

Association between Testicular Cancer and Epididymoorchitis: A Population-Based Case-Control Study.

Li-Ting Kao1,2, Herng-Ching Lin2, Shiu-Dong Chung2,3, Chao-Yuan Huang4,5.   

Abstract

Even though epididymoorchitis and testicular cancer (TC) may have similar pathophysiological pathways, no prior study has attempted to determine the association between these two diseases. This case-control study investigated the relationship between TC and prior epididymoorchitis by using a large population-based database. We used the Taiwan Longitudinal Health Insurance Database 2005 to select 372 patients who had received a diagnosis of TC and 3,720 age-matched controls without TC. We found that of the total sample of 4,092 patients, 53 (1.3%) had received a diagnosis of epididymoorchitis prior to the index date. Patients with TC had a higher prevalence of prior epididymoorchitis than that of patients without TC (11.0% vs. 0.3%, p < 0.001). Conditional logistic regression showed that prior epididymoorchitis was significantly associated with TC (crude OR = 38.24, 95% CI = 19.91-73.46). The association remained statistically significant even after adjustment for the other variables (OR = 47.17, 95% CI = 23.83-93.40). This study showed that patients with TC have higher odds of prior epididymoorchitis than do those without TC even after adjustment for potential confounders.

Entities:  

Mesh:

Year:  2016        PMID: 26975877      PMCID: PMC4791681          DOI: 10.1038/srep23079

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Testicular cancer (TC) is the commonest malignancy among young males, and its incidence has been increasing in many countries1. Although the pathophysiology of TC is still controversial, various studies have reported that TC might have multifactorial etiologies, such as cryptorchidism, inguinal hernia, birth order, and sibship234. In addition, there is increasing biological and epidemiologic evidence that some infections and infectious agents might increase the risk of TC5678910. Many authors have suggested that inflammatory mechanisms may promote cancer development1112. Thus, infections and inflammation may play important roles in the occurrence and progression of TC. However, to date, very few studies have explored the relationship between prevalent genitourinary infections and TC. Epididymoorchitis is a common inflammatory disease that affects the epididymis and the testis1314. It usually occurs in men between 18 and 35 years of age. Every year, approximately 600,000 patients in the United States experience the symptoms of epididymoorchitis14. Previous studies have shown that epididymoorchitis can be caused by a wide range of infections, including sexually transmitted infections, urinary infections, and viral infections13141516. These infections and the associated inflammation have been considered to be involved in the etiology of TC. Even though epididymoorchitis and TC may have similar infectious and inflammatory pathophysiological pathways, no prior study has attempted to determine the association between these two diseases. Therefore, we designed this case-control study to investigate the relationship between epididymoorchitis and TC by using a large population-based database in Taiwan.

Materials and Methods

Database

We retrieved the study sample from the Longitudinal Health Insurance Database 2005 (LHID2005), which was created by the Taiwan National Health Research Institutes. Taiwan initiated the single-payer National Health Insurance (NHI) program in 1995 to provide accessible and affordable healthcare for all residents. The LHID2005 includes all medical claims data for 1,000,000 beneficiaries, randomly sampled from among all enrollees (n = 25.68 million) in the NHI program. The LHID2005 provides a unique opportunity for researchers to trace the medical services availed of by these 1,000,000 beneficiaries since the beginning of the NHI program in 1995.

Selection of Cases and Controls

From the LHID2005, we identified 372 patients who had received a first-time diagnosis of TC (ICD-9-CM codes 186, 186.0, and 186.9) in ambulatory care visits (outpatient department of hospitals or clinics) or hospitalization between January 2001 and December 2013. We ensured that in all cases the diagnosis had been verified by a certified urologist on at least one occasion. The date of the first diagnosis of TC was denoted the index date for that patient. The controls were also selected from the LHID2005. We first excluded all subjects who had a history of TC. Subsequently, using the SAS PROC SURVEYSELECT program (SAS System for Windows, Version 8.2), we selected 3,720 controls, in a ratio of 10:1. The ten controls per case were matched according to age group (<18, 18–29, 30–39, 40–49, 50–59, and >59 years) and the index year; specifically, for each TC case, the controls were selected from among those who had utilized medical services in the index year of that particular case. The date of the first use of ambulatory care visits occurring in the index year was designated as the index date for the controls.

Exposure Assessment

From the medical claims data, we identified all patients who had received a diagnosis of epididymoorchitis (ICD-9-CM codes 604, 604.0, and 604.9) during ambulatory care visits at any time in the 3 years preceding the index date. We confirmed that the diagnoses were made by certified urologists.

Statistical Analysis

We used the SAS statistical package (SAS System for Windows, Version 8.2) for data analysis. Independent t test and Chi-square test were conducted to compare differences between the cases and controls in terms of the patients’ age, monthly income, geographic location, and urbanization level (five levels, with 1 being the most urbanized and 5 being the least). In addition, we explored the differences in medical comorbidities between the cases and controls by using the Pearson χ2 test. The comorbidities were inguinal hernia, cryptorchidism, testicular microlithiasis, and mumps orchitis, which have been identified by previous studies as potential risk factors for TC. These comorbidities were counted only if they were coded prior to the index date. We used conditional logistic regression (conditioned on the factors of age group and index year) to calculate the odds ratio (OR) and 95% confidence interval (CI) for having previously received an epididymoorchitis diagnosis between the cases and controls. A two-sided p value ≤0.05 was considered significant.

Results

Table 1 shows the distribution of the sociodemographic characteristics and comorbidities among the cases and controls. There were no significant differences in the mean age (p = 0.865) and monthly insured amount (p = 0.970) between the cases and controls. However, there were significant differences in urbanization and geographic region (p < 0.001). In addition, testicular microlithiasis was significantly more common in the cases than in the controls (p < 0.001).
Table 1

Sociodemographic characteristics and medical comorbidities of testicular cancer patients and controls (n = 4,092).

 Patients with Testicular Cancer n = 372
Controls n = 3,720
 
VariablesNo.(%)No.(%)p value
Age, mean (standard deviation)34.4 (18.9)34.2 (18.9)0.865  
Monthly insured income    0.970
 ≤NT$15,840194(52.2)1,932(51.9) 
 NT$15,841-25,00082(22.0)840(22.6) 
 ≥NT$25,00196(25.8)948(25.5) 
Urbanization level    <0.001
 190(24.2)1,158(31.1) 
 2118(31.7)1,058(28.4) 
 339(10.5)638(17.2) 
 445(12.1)468(12.6) 
 580(21.5)398(10.7) 
Geographic region    <0.001
 Northern14,321(37.9)1,844(49.6) 
 Central182(48.9)906(24.4) 
 Southern45(12.1)(920(24.7) 
 Eastern4(1.1)50(1.3) 
Inguinal hernia13(3.5)106(2.9)0.480
Cryptorchidism2(0.5)10(0.3)0.361
Testicular microlithiasis15(4.0)22(0.6)<0.001
Mumps orchitis0(0)2(0.1)--
Table 2 presents the relationship between TC and epididymoorchitis. Of the total sample of 4,092 patients, 53 (1.3%) had received a diagnosis of epididymoorchitis prior to the index date—41/372 (11.0%) cases and 12/3,720 (0.3%) controls. The chi-square test showed a statistically significant relationship between TC and prior epididymoorchitis (p < 0.001).
Table 2

Relationship between testicular cancer and prior epididymoorchitis (n = 4092).

Presence of Prior EpididymoorchitisPatients with Testicular Cancer n = 372
Controls n = 3720
 
No.%No.%p value
Yes41(11.0)12(0.3)<0.001
No331(89.0)3,708(99.7) 
Table 3 shows the crude and adjusted ORs for TC. Conditional logistic regression revealed that prior epididymoorchitis was significantly associated with TC (crude OR = 38.24, 95% CI = 19.91–73.46); this association remained statistically significant even after adjustment for testicular microlithiasis, geographic region and urbanization level (OR = 47.17, 95% CI = 23.83–93.40). Furthermore, after adjustment for the other variables, testicular microlithiasis was significantly associated with TC (adjusted OR = 5.88, 95% CI = 2.77–12.48).
Table 3

Crude and adjusted odds ratio for testicular cancer (n = 4092).

VariablesTesticular Cancer Occurrences
Crude OR (95% CI)p valueAdjusted OR (95% CI)p value
Prior epididymoorchitis38.24 (19.91–73.46)<0.00147.17 (23.83–93.40)<0.001
Urbanization level    
 11.00 1.00 
 21.44 (1.08–1.91)0.0141.29 (0.94–1.77)0.110
 30.79 (0.53–1.16)0.2250.56 (0.37–0.87)0.009
 41.24 (0.85–1.80)0.2640.72 (0.47–1.12)0.145
 52.59 (1.87–3.57)<0.0011.80 (1.24–2.61)0.002
Geographic region    
 Northern1.00 1.00 
 Central2.63 (2.08–3.32)<0.0012.98 (2.26–3.95)<0.001
 Southern0.64 (0.45–0.90)0.01110.59 (0.40–0.86)0.006
 Eastern1.05 (0.37–2.94)0.93160.86 (0.27–2.79)0.801
Testicular microlithiasis7.06 (3.63–13.74)<0.0015.88 (2.77–12.48)<0.001

Note: The adjusted odds ratios were derived from a conditional logistic regression model and adjusted for potential confounders.

Discussion

This population-based case-control study showed that prior epididymoorchitis was significantly associated with TC even after adjustment for some potential confounders. Many previous studies have investigated the association between TC and factors such as cryptorchidism, inguinal hernia, birth order, and infertility234171819. Epidemiologic studies and meta-analysis have also attempted to demonstrate the relationship between TC and mumps orchitis2782021. However, in our review of the literature, we could not find any study that has examined the association between TC and prior epididymoorchitis; this is surprising because these two diseases might have similar pathophysiological mechanisms, and epididymoorchitis is more common than isolated orchitis14. The mechanisms underlying the relationship between epididymoorchitis and TC are still uncertain. The greater odds of prior epididymoorchitis in patients with TC in comparison with those without TC might be explained by the infection and subsequent inflammatory mechanisms. Some studies have documented the potential connection between TC and infections5910222324. A study in the 1980s was the first to suggest an infectious etiology for TC because of its epidemiologic similarities with Hodgkin disease22. Since then, increasing biological and epidemiologic evidence has supported the possibility that some infectious agents might increase the risk of the development of TC. For instance, one study reported a significantly increased risk of TC among patients infected with human immunodeficiency virus23. Other studies have suggested that the Epstein-Barr virus and the cytomegalovirus may be involved in the etiology of TC591024. Studies in the United Kingdom have indicated an elevated risk of TC in patients with a history of sexually transmitted disease or Neisseria gonorrhoeae infection67. Epididymoorchitis is mostly an infectious disease that is caused by a broad range of infections, including sexually transmitted infections (such as infection with N. gonorrhoeae and Chlamydia trachomatis), urinary tract infections, and other bacterial and viral infections14152526. Therefore, these pathogens and the infectious process have been considered to be involved in the etiology of both epididymoorchitis and TC. The inflammatory process associated with infections may also be a major factor in TC development. According to the literature, epididymoorchitis is a frequent cause of scrotal pain, which is an indication of inflammation of the epididymis and testis1425. Epididymoorchitis elicits inflammatory responses, such as increases in the number of leukocytes and levels of proinflammatory cytokines27. Many recent studies have shown that inflammation may play a key role in cancer growth and progression122829. The chronic inflammation associated with infections could promote tumor development29. In addition, some tumors have been reported to arise from areas of infections and inflammation11. Therefore, the abnormal inflammatory responses in patients with epididymoorchitis might lead to the progression and exacerbation of TC. The particular strength of this case-control study was the use of the LHID2005—a large population-based dataset with wide health benefit coverage in Taiwan. This enabled us to obtain a large sample and thus increase the statistical power of the study. Use of this database helped us avoid any selection bias and, because the LHID2005 includes most of the relevant medical data for selected patients since they entered the healthcare system in Taiwan, we could eliminate the possibility of a recall bias. There are, however, several limitations that must be considered. First, the LHID2005 does not provide information on bacterial cultures and the severity of TC (e.g., TNM classification), which are considered to affect the potential association between epididymoorchitis and TC1030. Second, this administrative dataset does not provide information on genetic factors, maternal risk factors, and lifestyle factors, including a family history of cancer, maternal bleeding, and cigarette smoking and therefore we could not adjust for these confounding factors in this study41030. Third, although the LHID2005 is a population-based dataset, it might not include all patients who have had epididymoorchitis in Taiwan; several patients with mild symptoms might not have sought medical treatment. Finally, most of the selected patients in this study were of Chinese ethnicity and therefore the generalization of the findings to other ethnic groups is not possible. In conclusion, this population-based case-control study shows that patients with TC had higher odds of prior epididymoorchitis than did those without TC even after adjustment for potential confounders. We recommend that physicians be alert to this relationship in patients with a history of epididymoorchitis and recommend regular urological examinations for such patients. Additional biological studies are required to define the actual mechanisms underlying the association between epididymoorchitis and TC.

Additional Information

How to cite this article: Kao, L.-T. et al. Association between Testicular Cancer and Epididymoorchitis: A Population-Based Case-Control Study. Sci. Rep. 6, 23079; doi: 10.1038/srep23079 (2016).
  29 in total

Review 1.  Acute epididymitis.

Authors:  G A Luzzi; T S O'Brien
Journal:  BJU Int       Date:  2001-05       Impact factor: 5.588

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Epidemiologic comparison of cancer of the testis and Hodgkin's disease among young males.

Authors:  G R Newell; P K Mills; D E Johnson
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

Review 4.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 5.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

6.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

7.  A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life.

Authors:  Stefanie Zhao Lin Lip; Louise Elizabeth Denheen Murchison; Paul Stephen Cullis; Lindsay Govan; Robert Carachi
Journal:  Arch Dis Child       Date:  2012-11-28       Impact factor: 3.791

8.  Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data.

Authors:  B Trabert; B I Graubard; R L Erickson; K A McGlynn
Journal:  Br J Cancer       Date:  2012-02-16       Impact factor: 7.640

Review 9.  Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.

Authors:  Jenny E Elzinga-Tinke; Gert R Dohle; Leendert Hj Looijenga
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

10.  Testicular cancer and antecedent diseases.

Authors:  A J Swerdlow; S R Huttly; P G Smith
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

View more
  2 in total

1.  Predictive and prognostic impact of preoperative complete blood count based systemic inflammatory markers in testicular cancer.

Authors:  Ersan Arda; Gurkan Arikan; Hakan Akdere; Murat Akgul; Ilkan Yuksel
Journal:  Int Braz J Urol       Date:  2020 Mar-Apr       Impact factor: 1.541

2.  Acute epididymo-orchitis: relevance of local classification and partner's follow-up.

Authors:  Oleg Banyra; Oleg Nikitin; Iryna Ventskivska
Journal:  Cent European J Urol       Date:  2019-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.